U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093736) titled 'A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders' on July 12.
Brief Summary: The goal of this clinical trial is to learn if the Fisher Wallace Stimulator FW-200 experimental device is effective at treating self-reported anxiety in first responders. The main question the trial aims to answer is does the FW-200 device improve anxiety as measured by a validated questionnaire.
Study Start Date: July 06, 2021
Study Type: INTERVENTIONAL
Condition:
Anxiety
Intervention:
DEVICE: FW-200
Non-invasive, home-use...